The NEPI antidiabetes study (NANSY). 1: short-term dose-effect relations of glimepiride in subjects with impaired fasting glucose.

about

Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

P2860

Q30243879-FE4F5241-0716-456B-A352-1DD9C816ACCE

P2860

The NEPI antidiabetes study (NANSY). 1: short-term dose-effect relations of glimepiride in subjects with impaired fasting glucose.

Item

http://www.wikidata.org/entity/Q43923317

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

The NEPI antidiabetes study (N ...... with impaired fasting glucose.

@en

The NEPI antidiabetes study

@nl

type

Item

label

The NEPI antidiabetes study (N ...... with impaired fasting glucose.

@en

The NEPI antidiabetes study

@nl

prefLabel

The NEPI antidiabetes study (N ...... with impaired fasting glucose.

@en

The NEPI antidiabetes study

@nl

P1476

The NEPI antidiabetes study (N ...... with impaired fasting glucose.

@en

P2093

A Melander

http://www.w3.org/2001/XMLSchema#string

A Sjöstrand

http://www.w3.org/2001/XMLSchema#string

K Lindwall

http://www.w3.org/2001/XMLSchema#string

NEPI Antidiabetes Sstudy (NANSY)

http://www.w3.org/2001/XMLSchema#string

U Lindblad

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Cardiovascular effects of conventional sulfonylureas and glimepiride.

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

Glucose tolerance and mortality, including a substudy of tolbutamide treatment.

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

Impaired effect of sulfonylurea following increased dosage.

P304

443-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1463-1326.2001.00166.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jonas Ranstam

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11903417

http://www.w3.org/2001/XMLSchema#string

The NEPI antidiabetes study (NANSY). 1: short-term dose-effect relations of glimepiride in subjects with impaired fasting glucose.

about

P2860

P2860

The NEPI antidiabetes study (NANSY). 1: short-term dose-effect relations of glimepiride in subjects with impaired fasting glucose.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698